Noticias de AMGN_US
Noticias del mercado
Últimas noticias sobre AMGN_US — 702 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Amgen stock closed at USD 382.47 on Nasdaq on September 10, 2026 after a 2.2 percent drop tied to an
Here is how Amgen (AMGN) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
Amgen Inc. (NASDAQ:AMGN) and AstraZeneca PLC (NYSE:AZN) received a positive boost after their combination of Amgen’s Imdelltra and AstraZeneca’s Imfinzi significantly improved overall survival in a late-stage trial involving patients with extensive-stage small-cell lung cancer. The combination was tested as a maintenance treatment against Imfinzi alone in patients whose disease had not progressed after initial […]
The Manufacturers Life Insurance Company lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 8.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,150,794 shares of the medical research company
At the close on September 10, 2026, Amgen stock finished at USD 382.47 on Nasdaq, down 2.25 percent
Amgen stock faces pressure after HSBC downgraded the shares to Hold on September 10, 2026, lowering
AMGN - AMGEN Inc - Stock screener for investors and traders, financial visualizations.
The latest trading day saw Amgen (AMGN) settling at $382.47, representing a -2.25% change from its previous close.
Página 10 de 36